Apimeds Pharmaceuticals U...

NYSE: APUS · Real-Time Price · USD
1.84
0.09 (5.14%)
At close: Aug 19, 2025, 3:59 PM
1.82
-1.09%
After-hours: Aug 19, 2025, 07:57 PM EDT

Apimeds Pharmaceuticals US Inc Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-1.28M -747.44K -639.53K -1.02M
Interest Income
2.82K 7.81K n/a n/a
Pretax Income
-1.39M -777.69K -668.67K -1.03M
Net Income
-1.39M -777.69K -668.67K -1.03M
Selling & General & Admin
1.28M 648.89K 271.53K 529.55K
Research & Development
n/a 98.54K 368K 489.94K
Other Expenses
n/a n/a n/a n/a
Operating Expenses
1.28M 747.44K 639.53K 1.02M
Interest Expense
117.72K 38.07K 29.14K 6.74K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
1.28M 747.44K 639.53K 1.02M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
11.53M 11.53M 11.53M 11.53M
Shares Outstanding (Diluted)
12.69M 12.69M 12.69M 12.69M
EPS (Basic)
-0.12 -0.07 -0.06 -0.09
EPS (Diluted)
-0.11 -0.06 -0.05 -0.08
EBITDA
-1.27M -739.63K -639.53K -1.02M
EBIT
-1.27M -739.63K -639.53K -1.02M
Depreciation & Amortization
n/a n/a n/a n/a